Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Current-Liabilities" stands at 24.80 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Other Current Liabilities" stands at 24.80 Billion USD. This represents an increase of 11.40 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 56.63 percent compared to the value the year prior.
The 1 year change in percent is 56.63.
The 3 year change in percent is 114.93.
The 5 year change in percent is 182.29.
The 10 year change in percent is 286.63.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Other Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Liabilities | 280,205,508,085.11 |
![]() | Novartis AG - Other Current Liabilities | 255,096,620,580.91 |